[November 19, 2014]

GE Healthcare Announces Omnyx™ Digital Pathology Collaboration with Caradigm

GE Healthcare, a leader in technology innovation, today announced it will resell Caradigm's Single Sign-On and Context Management solutions in the United States, Canada, and specific EU countries to provide connectivity between the Omnyx™ digital pathology platforms and designated Anatomic Pathology Laboratory Information Systems (APLIS).

When pathologists diagnose cancers, they evaluate tissue in the context of a patient's history, order more tests on the tissue if necessary, and deliver their findings to an oncologist*. The oncologist then uses the pathologist's report to determine the course of treatment. For pathologists, the combination of Omnyx and APLIS software solutions to view whole slide images and to render patient reports streamlines the completion of these tasks.

The collaboration with Caradigm streamlines the workflow of pathologists by using Caradigm's Single Sign-On and Context Management software from its Identity and Access Management (IAM) suite of products to connect the Omnyx™ platform and the APLIS to give pathologists quicker, more secure access to laboratory applications and patient data.

"Digital pathology will enable pathologists to collaborate with other clinicians and patients. This level of connectivity is essential to derive patient-centered care and efficiency," says Mamar Gelaye, CEO, Omnyx. "Using Caradigm Single Sign-On and Context Management software in conjunction with Omnyx solutions, the pathologist will confidently be able to have the right access to the right application and the right data without interruption to their clinical workflow."

Sandy Murti, Vice President of Partnerships & Alliances for Caradigm, adde, "Caradigm's IAM products are designed exclusively to meet the complex needs of healthcare organizations challenged to make the right data available at the right time to the right caregivers. We're excited to work with GE Healthcare and Omnyx to make it easier for pathologists to rapidly and securely access data as they provide care for cancer patients."

*In the US, the Omnyx^TM IDP is for in vitro diagnostic use for a specific clinical application, and is intended for research use only on other applications.

Omnyx^TM is a trademark of Omnyx, LLC.

Caradigm® is a trademark of Caradigm USA LLC.

About GE Healthcare

GE Healthcare provides transformational medical technologies and services to meet the demand for increased access, enhanced quality and more affordable healthcare around the world. GE (NYSE:GE) works on things that matter - great people and technologies taking on tough challenges. From medical imaging, software & IT, patient monitoring and diagnostics to drug discovery, biopharmaceutical manufacturing technologies and performance improvement solutions, GE Healthcare helps medical professionals deliver great healthcare to their patients.

About Caradigm

Caradigm® is a healthcare analytics and population health company dedicated to helping organizations improve care, reduce costs and manage risk. Caradigm analytics solutions provide deep insight into patients, populations, processes and performance, enabling healthcare organizations to understand their clinical and financial risk and identify the actions needed to address it. Caradigm population health solutions enable teams to deliver the appropriate care to patients through effective coordination and patient engagement from hospital to clinic to home, improving outcomes and financial results. The key to Caradigm analytics and population health solutions is a rich set of clinical, operational and financial data delivered to healthcare professionals within their workflows in near real time. This data asset serves as the foundation for a growing number of innovative healthcare applications developed by Caradigm and industry partners, providing rapid incremental value to customers.

About Omnyx

Omnyx, LLC is a joint venture of GE Healthcare and UPMC (University of Pittsburgh Medical Center) with locations in Pittsburgh, PA and Piscataway, NJ. The company has developed the Omnyx^TM IDP solution allowing pathology departments worldwide to move to an all-digital workflow. Their products include image acquisition devices, workflow software, and transformation consulting. Close collaboration with pathologists at UPMC and other institutions along with their relationship with GE Healthcare allows Omnyx to focus its innovation on the needs of anatomic pathologists worldwide. Omnyx^TM products are for in vitro diagnostic use for specific clinical applications, and are intended for research use only on other applications. For more information, go to: omnyx.com.

[ Back To TMCnet.com's Homepage ]